Skip to main content

Table 2 Perioperative and postoperative data

From: Video-Assisted Thoracoscopic Surgery vs Thoracotomy for Non-Small Cell Lung Cancer Greater Than 5 cm: Is VATS a feasible approach for large tumors?

Variables

VATS (n = 24)

Thoracotomy (n = 36)

P Values

Maximum dimension of the tumor (cm) (mean ± SD)

6.93 ± 1.61

7.43 ± 2.09

0.26

Pathology (n (%))

  

0.031

 Adenocarcinoma

14(58.3)

23(63.9)

 

 Squamous cell carcinoma

7(29.2)

11(30.6)

 

 Large cell carcinoma

3(12.5)

2(5.6)

 

Operation (n (%))

  

0.237

 Lobectomy

22(91.6)

26(72.2)

 

 Bilobectomy

1(4.2)

10(27.8)

 

 Pneumonectomy

1(4.2)

0(0)

 

Operative duration (minutes) (mean ± SD)

228.75 ± 91.88

260.17 ± 102.78

0.784

Overall number of nodal stations dissected (mean ± SD)

5.13 ± 1.26

4.89 ± 1.03

0.352

Intraoperative complication (n (%))

1(5)a

2(5.6)

0.240

Drainage time(days) (mean ± SD)

5.00 ± 3.43

8.14 ± 4.95

0.009

Length of stay (days) (mean ± SD)

5.42 ± 2.32

9.11 ± 5.31

0.001

Nodal status (n (%)

  

0.494

N0

17(70.8)

22(61.1)

 

N1

5(20.8)

7(19.4)

 

N2

2(8.3)

7(19.4)

 

Postoperative pathological staging (n (%))

  

0.914

 Stage II

9(37.5)

14(38.9)

 

 Stage III

15(62.5)

22(61.1)

 

Follow-up time(months) (mean ± SD)

27.67 ± 6.02

26.36 ± 5.24

0.784

Adjuvant therapy (n (%))

17(70.8)

26(72.2)

1.00

Time interval between surgery and adjuvant therapy (days) (mean ± SD)

43.71 ± 14.45

49.96 ± 15.04

0.081

  1. SD Standard deviation
  2. aA total of 25 patients started with VATS, one patient converted into thoracotomy because of intraoperative bleeding